Brief: Theratechnologies Announces Preliminary Q4 And Full Year 2020 Revenues

Theratechnologies

07/01/2021 12:22

Jan 7 (Reuters) - Theratechnologies Inc  TH.TO :
    * THERATECHNOLOGIES ANNOUNCES PRELIMINARY FOURTH QUARTER AND
FULL
FISCAL YEAR 2020 REVENUES AND PROVIDES UPDATE ON RESEARCH AND
DEVELOPMENT ACTIVITIES
    * CONSOLIDATED NET REVENUES FOR CO'S Q4 FISCAL YEAR 2020 ARE
EXPECTED TO BE BETWEEN US$18.9 MILLION AND US$19.2 MILLION
    * CONSOLIDATED NET REVENUES FOR CO'S FULL FISCAL YEAR 2020
ARE
EXPECTED TO BE BETWEEN US$65.8 MILLION AND US$66.1 MILLION
    * THERATECHNOLOGIES- RECEIVES 'STUDY MAY PROCEED' LETTERS
FROM FDA
FOR PHASE 3 TRIAL OF TESAMORELIN IN NASH, PHASE 1 TRIAL OF
TH1902 IN VARIOUS CANCERS
    * Q4 REVENUE VIEW $18.1 MILLION -- REFINITIV IBES DATA
    * FY2020 REVENUE VIEW $64.8 MILLION -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX7Ws7cL 
Further company coverage:  TH.TO 

 ((Reuters.Briefs@thomsonreuters.com;))